Immunoelectrophoretic changes in Lyell syndrome.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000150:complications; D000510:Alpha-Globulins / Q000032:analysis; D000983:Antipyrine / Q000009:adverse effects; D001609:Beta-Globulins / Q000032:analysis; D001796:Blood Protein Disorders / Q000209:etiology / Q000276:immunology*; D001797:Blood Protein Electrophoresis; D002570:Ceruloplasmin / Q000032:analysis; D002701:Chloramphenicol / Q000009:adverse effects; D005260:Female; D006801:Humans; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008074:Lipoproteins / Q000032:analysis; D008297:Male; D008698:Mesylates / Q000009:adverse effects; D008875:Middle Aged; D011379:Prognosis; D011498:Protein Precursors / Q000032:analysis; D012709:Serum Albumin / Q000032:analysis; D013262:Stevens-Johnson Syndrome / Q000150:complications / Q000209:etiology / Q000276:immunology*; D013577:Syndrome; D014168:Transferrin / Q000032:analysis; D000515:alpha 1-Antitrypsin / Q000032:analysis; D005719:gamma-Globulins / Q000032:analysis
D000510:Alpha-Globulins; D001609:Beta-Globulins; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D008074:Lipoproteins; D008698:Mesylates; D011498:Protein Precursors; D012709:Serum Albumin; D014168:Transferrin; D000515:alpha 1-Antitrypsin; D005719:gamma-Globulins; D002701:Chloramphenicol; D002570:Ceruloplasmin; D000983:Antipyrine